Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation

Bone Marrow Transplantation

Volumn 23, Issue 11, 1999, Pages 1161-1165

  Sobecks, R M ^a,b   Le Beau, M M ^a   Anastasi, J ^a   Williams, S F ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Autologous bone marrow peripheral blood stem cell transplantation; Cytogenetics; Therapy related leukemia

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CYTOGENETICS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; HUMAN CELL; INCIDENCE; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASIA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; T CELL LEUKEMIA; UNITED STATES;

EID: 0033009473     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701781     Document Type: Article

References (16)

1. Darrington DL, Vose JM, Anderson JR et al. Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies. J Clin Oncol 1994; 12: 2527-2534.
2. Traweek ST, Slovak ML, Nademanee AP et al. Clonal karyotypic hematopoietic cell abnormalities occurring after autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma. Blood 1994; 84: 957-963.
3. Stone RM, Neuberg D, Soiffer R et al. Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma. J Clin Oncol 1994; 12: 2535-2542.
4. Miller JS, Arthur DC, Litz CE et al. Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy. Blood 1994; 83: 3780-3786.
5. Laughlin MJ, McGaughey DS, Crews JR et al. Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant. J Clin Oncol 1998; 16: 1008-1012.
6. Roman-Unfer S, Bitran JD, Hanauer S et al. Acute myeloid leukemia and myelodysplasia following intensive chemotherapy for breast cancer. Bone Marrow Transplant 1995; 16: 163-168.
7. Govindarajan R, Jagannath S, Flick JT et al. Preceding standard therapy is the likely cause of MDS after autotransplants for multiple myeloma. Br J Haematol 1996; 95: 349-353.
8. Chan T, Juneja S, Wolf M et al. Secondary myelodysplastic syndrome following bone marrow transplantation: report of two cases. Bone Marrow Transplant 1994; 13: 145-148.
9. Coleman CN, Williams CJ, Flint A et al. Hematologic neoplasia in patients treated for Hodgkin's disease. New Engl J Med 1977; 297: 1249-1252.
10. Pedersen-Bjergaard J, Ersbol J, Sorensen HM et al. Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphoma. Ann Intern Med 1985; 103: 195-200.
11. Rosati S, Mick R, Xu F et al. Refractory cytopenia with multi-lineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome. Leukemia 1996; 10: 20-26.
12. ISCN (1995). An International System for Human Cytogenetic Nomenclature. Mitelman F (ed). Karger: Basel, 1995.
13. Archimbaud E, Charrin C, Guyotat D et al. Acute leukaemia with t(4;11) in patients previously exposed to carcinogens. Br J Haematol 1988; 69: 467-470.
14. Sobecks RM, Zimmerman TM, Grinblatt DL et al. A phase II trial of high-dose late intensification therapy in patients with chemotherapy sensitive multiple myeloma. Blood 1997; 90 (Suppl. 1, part 2): 408b (Abstr. 4582).
15. Le Beau MM, Albain KS, Larson RA et al. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndrome and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes 5 and 7. J Clin Oncol 1986; 4: 325-345.
16. Chao NJ, Nademanee AP, Long GD et al. Importance of bone marrow cytogenetic evaluation before autologous bone marrow transplantation for Hodgkin's disease. J Clin Oncol 1991; 9: 1575-1579.